Arcutis Canada Przoryve Cream 0.05% Receives Health Canada Approval For Atopic Dermatitis

ARQT•2026-08-20

Health Canada approves Przoryve Cream 0.05%

Arcutis Biotherapeutics, Inc. said Przoryve Cream 0.05% has received Health Canada approval for children aged 2 to 5 years with mild to moderate atopic dermatitis.

Arcutis Canada Przoryve Cream 0.05% Receives Health Canada Approval For Atopic Dermatitis

Health Canada approves Przoryve Cream 0.05%

Related News

Nvidia to ship AI chip for China by year-end, The Information reports

Wall St hits two-week lows as rising bond yields, Walmart results drag

Nasdaq trade halt continues <SVA.O> reason not available at 12:46 PM

Genentech Announces Manufacturing Expansion In Hillsboro, Oregon

ESS Tech prices private placement warrants for 12,800,000 shares at $0.5 each